Study volunteers play a critical role in the discovery of new treatments, therapies, ways of diagnosing different diseases, and the advancement of medicine. Our team is dedicated to providing with all information available to help you make an informed decision as to whether or not joining a study or trial is right for yourself or a loved one. See below for a list of our currently enrolling clinical trials.

We are always adding new trials to the list, sign up for our e-mail list to be notified about upcoming trials.

By signing up for our email list, you agree to receive emails about our enrolling studies. You may unsubscribe at any time.

Currently Enrolling Clinical Trials

Please fill out our Interest Form below if you are interested in learning more about our trials.

Asthma

The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI).

COPD

Depemokimab is being developed as a treatment for individuals with moderate to severe COPD. The aim of this study is to assess the efficacy and safety of depemokimab compared as an add-on medicine in participants with uncontrolled moderate to severe COPD with type 2 inflammation.

Knee Pain and Excess Weight

The YDAN master protocol will support two independent studies, J3R-MC-YOA1 and J3R-MC-YOA2. Each study will investigate how well and safely Eloralintide (LY3841136) works in adults with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last about 75 weeks, including screening.

Dermatomyositis and Polymyositis

The purpose of the study is to understand how the study medicine PF-06823859 (dazukibart) works in people with idiopathic inflammatory myopathies (DM and PM). These disorders cause inflammation that weakens the muscles that are important for movement and may also cause skin rash in people with DM.

Myasthenia Gravis

Multiple studies currently enrolling

1. A study to evaluate the efficacy, safety and tolerability of Remibrutinib versus placebo in adult patients with Generalized Myasthenia Gravis who are on stable, standard-of-care (SOC) treatment.

2. Study to assess the efficacy, safety and tolerability of IMVT-1402 in adult participants with mild to severe generalized myasthenia gravis.

Interest Form

Please take a moment to fill this form and our team will contact you within 1-2 business days.

First Name

Last Name

Phone Number

Please select the best time to reach you:

Early Morning (7:00AM-11:00AM)

Late Morning/Early Afternoon (11:00AM-1:00PM)

Afternon (1:00-5:00PM)

After Hours (5:00-6:30PM)

Please let us know what studies you would like to learn more about

How did you hear about us?

Please select th best method to contact you:

Text Message

Phone Call

All the information you provide us is kept confidential and will only be used by our team to get in touch with you. Your information will not be shared with any other parties outside the Evolve Clinical Research team.
By submitting this form, you agree to be contacted about your enrolling clinical trials by the method selected/

Thanks for submitting!